Qsymia as an Adjunct to Surgical Therapy in the Superobese

Completed · Phase 2

Conditions studied: Obesity, Metabolic Surgery, Weight Loss, Bariatric Surgery Procedures

In brief

This study tests the efficacy of the medication, Qsymia, as an adjunct therapy in superobese individuals planning to undergo weight loss surgery. Individuals taking the medication before and after surgery will be compared to historical controls who had surgery without taking the medication.

Key facts

Study ID
NCT02301416
Run by
Wake Forest University Health Sciences
People needed
25
Starts
2014-12-01
Expected to finish
2018-06-27
Last updated by the study team
2019-09-04

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.